A detailed history of State Street Corp transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 3,317,936 shares of IDYA stock, worth $91.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,317,936
Previous 2,874,296 15.43%
Holding current value
$91.1 Million
Previous $101 Million 4.16%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $13.5 Million - $19.1 Million
443,640 Added 15.43%
3,317,936 $105 Million
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $9.96 Million - $12.6 Million
-289,658 Reduced 9.15%
2,874,296 $101 Million
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $5.88 Million - $8.11 Million
172,055 Added 5.75%
3,163,954 $139 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $20.8 Million - $30.3 Million
844,399 Added 39.32%
2,991,899 $106 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $189,566 - $267,840
8,997 Added 0.42%
2,147,500 $57.9 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $322,399 - $617,468
24,186 Added 1.14%
2,138,503 $50.3 Million
Q1 2023

May 15, 2023

SELL
$13.49 - $18.72 $2.81 Million - $3.9 Million
-208,324 Reduced 8.97%
2,114,317 $29 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $6.11 Million - $7.67 Million
422,260 Added 22.22%
2,322,641 $42.2 Million
Q3 2022

Nov 15, 2022

BUY
$9.24 - $15.79 $3.86 Million - $6.6 Million
418,227 Added 28.22%
1,900,381 $28.4 Million
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $3.21 Million - $5.39 Million
-388,216 Reduced 20.76%
1,482,154 $20.5 Million
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $1.99 Million - $4.27 Million
177,663 Added 10.5%
1,870,370 $20.9 Million
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $13.7 Million - $17.6 Million
653,006 Added 62.81%
1,692,707 $40 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $11.4 Million - $17.8 Million
658,543 Added 172.77%
1,039,701 $26.5 Million
Q2 2021

Aug 16, 2021

BUY
$17.76 - $24.83 $2.31 Million - $3.23 Million
130,090 Added 51.81%
381,158 $8 Million
Q1 2021

May 17, 2021

BUY
$13.48 - $23.77 $285,021 - $502,592
21,144 Added 9.2%
251,068 $5.9 Million
Q4 2020

Feb 16, 2021

BUY
$12.17 - $17.52 $265,792 - $382,636
21,840 Added 10.5%
229,924 $3.22 Million
Q3 2020

Nov 10, 2020

BUY
$11.22 - $14.46 $449,450 - $579,238
40,058 Added 23.84%
208,084 $2.61 Million
Q2 2020

Aug 14, 2020

BUY
$3.59 - $18.57 $603,213 - $3.12 Million
168,026 New
168,026 $2.39 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.32B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.